0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Researchers Express Heartfelt Wishes for Success of Molecular Biology Techniques in Cardiac Care

Marsha F. Goldsmith
JAMA. 1991;265(1):16-17. doi:10.1001/jama.1991.03460010014004.
Text Size: A A A
Published online

ABSTRACT

MILKING SHEEP to obtain the material for lifesaving drugs may come to seem no stranger than keeping flocks to provide the basis for Roquefort cheese, if experimental molecular biology procedures already under way are adopted someday. At the 63rd Scientific Sessions of the American Heart Association, held in Dallas, Tex, investigators discussed the use of recombinant DNA technology to combat cardiac (and other) disorders more directly than was ever possible before.

"At the present time," says Robert Roberts, MD, chief of cardiology, Baylor College of Medicine, Houston, Tex, "the Food and Drug Administration has approved only about 10 drugs that are made by recombinant DNA. The agency estimates that, by the year 2000, more than 50% of all approved drugs will be made by this method."

(A spokesman for the Pharmaceutical Manufacturers Association estimates that there are currently approximately 3500 approved "chemical entities [drugs]." He said 104 recombinant drugs await

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Figures

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();